About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and ... - Nanoscale (RSC Publishing) DOI:10.1039/C5NR01496D
PDF) Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes
PDF) Effect of pulmonary surfactant on the dissolution, stability and uptake of zinc oxide nanowires by human respiratory epithelial cells
Curosurf
Pa O 2 after surfactant lavage in Infasurf, KL4-Surfactant, Exosurf and... | Download Scientific Diagram
The LISAcath catheter (left) and Angiocath catheter (right). | Download Scientific Diagram
Chiesi Enhances Asthma Portfolio with Acquisition of Atopix Therapeutics
PDF) Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes
Ioannis Gianniotis - Medical Representative - Chiesi Hellas | LinkedIn
Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and ... - Nanoscale (RSC Publishing) DOI:10.1039/C5NR01496D
Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and ... - Nanoscale (RSC Publishing) DOI:10.1039/C5NR01496D
PDF) Comparison Outcome of Surfactant Administration Via Tracheal Catheterization During Spontaneous Breathing with Insure
Influence of surfactant preparations on proliferation ability of... | Download Scientific Diagram
PDF) Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes
PDF) Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes
PDF) Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes
About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
Ioannis Gianniotis - Medical Representative - Chiesi Hellas | LinkedIn
About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
PDF) Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes
PDF) Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes
Chiesi, Research and Development
Service Customer Service Patientservice Medical Suggestions Pharmacovigilance data privacy/ cookies Products Sustainability Our approach We ACT - Sustainability Manifesto Environment Supply Chain Sustainability Ethics and Transparency ...
Chiesi Hellas
Chiesi Farmaceutici completes the acquisition of European Marketing Rights
